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When targeted to sequences adjacent to a TATA element, pyrrole-imidazole (Py-Im) polyamides inhibit the
DNA binding activity of TATA box binding protein (TBP) and basal transcription by RNA polymerase II. In
the present study, we scanned the human immunodeficiency virus type 1 promoter for polyamide inhibition of
TBP binding and transcription using a series of DNA constructs in which a polyamide binding site was placed
at various distances from the TATA box. Polyamide interference with either TBP-DNA or TFIID-TFIIA-DNA
contacts both upstream and downstream of the TATA element resulted in inhibition of transcription. Our
results define important protein-DNA interactions outside of the TATA element and suggest that transcription
inhibition of selected gene promoters can be achieved with polyamides that target unique sequences within
these promoters at a distance from the TATA element. Our studies also demonstrate the utility of the Py-Im
polyamides for discovery of functionally important protein-DNA contacts involved in transcription.
Pyrrole-imidazole (Py-Im) polyamides are synthetic ligands
that can be designed to bind predetermined DNA sequences
(40, 44). These minor-groove DNA-binding molecules block
eukaryotic transcription factors from binding to their cognate
DNA sequences and inhibit transcription, both in vitro and, in
a few cases, in cell culture experiments (reviewed in reference
13). Polyamides are effective inhibitors of tissue-specific and
general transcription factors (7, 8) as well as viral repressors
(9) and transactivators (29). Recently, activation of gene ex-
pression has been achieved in vitro by tethering a small peptide
activation domain to a sequence-specific Py-Im polyamide
(31). Remarkably, activation and repression of selected genes
have been achieved in Drosophila melanogaster by targeting
polyamides to highly repeated satellite DNA sequences (17,
18).
Since batteries of genes utilize common general and tissue-
specific transcription factors, polyamides have been synthe-
sized to bind sequences adjacent to the binding sites for re-
quired transcription factors (7). A polyamide targeted to
sequences adjacent to the human immunodeficiency virus type
1 (HIV-1) TATA box effectively inhibits TATA box binding
protein (TBP) binding and basal transcription by RNA poly-
merase II (7). The binding of the TBP subunit of TFIID in the
minor groove nucleates assembly of the polymerase II tran-
scription machinery for TATA-containing genes (24, 25). Since
TFIID and the other general transcription factors TFIIA, -B,
-E, -F, and -H (28, 33) occupy at least 40 bp of promoter DNA
upstream from the transcription start site of mRNA-coding
genes, this raises the question of whether sites nonoverlapping
and distant from the TATA box might also serve as effective
polyamide targets for inhibition of transcription. To address
this issue, we generated a series of DNA constructs in which a
common polyamide-binding site was scanned through a pro-
moter and determined the effect of binding site position on
inhibition of TBP binding and basal RNA polymerase II tran-
scription. Our results show that essential protein-DNA con-
tacts on the HIV-1 core promoter are not simply restricted to
the TATA box and initiator element (20, 45) but rather extend
both upstream and downstream of the TATA box. Some of
these contacts are likely due to TFIID, the multiprotein com-
plex containing TBP. Importantly, transcription inhibition can
be achieved by targeting polyamides to promoter sequences
distant from the TATA element that are gene specific. Py-Im
polyamides thus provide simple and convenient chemical
probes for discovery of functionally important protein-DNA
contacts within specific gene promoters.
MATERIALS AND METHODS
Polyamide synthesis and characterization. Three Py-Im polyamides (1–3),
whose structures are shown in Fig. 1A, were synthesized by solid-phase methods
(1). Polyamide-EDTA conjugates were also prepared (40). The purity and iden-
tity of each compound were verified by analytical high-pressure liquid chroma-
tography, 1H nuclear magnetic resonance, and matrix-assisted laser desorption
ionization–time of flight mass spectrometry (1). The polyamides were dissolved
in distilled water and maintained as frozen stock solutions at approximately a 200
M concentration. Polyamide concentrations were determined by measurement
of UV absorbance at 308 nm using empirically determined extinction coefficients.
Site-directed mutagenesis. The sequence of the HIV-1 promoter contained
within plasmid pLTR-CAT (35) was altered by oligonucleotide-directed mu-
tagenesis in order to insert the binding site for a polyamide at various distances
upstream and downstream from the TATA element. This was accomplished with
the QuickChange mutagenesis kit from Stratagene and appropriate mutagenic
oligonucleotides (Genosys, Woodlands, Tex.). In each instance, the mutagenic
oligonucleotide contained polyamide-binding site sequence 5-AGCTCGT-3
and various lengths of wild-type HIV-1 flanking sequence. The oligonucleotides
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ranged in length from 27 to 35 bases and were designed to minimize secondary
structure effects with software obtained from the Genosys web site (www
.genosys.com). The resulting clones were verified by DNA sequence analysis in
the Scripps Core Facility.
DNase I footprint titrations and EMSA. Singly end-labeled DNA restriction
fragments were derived from HIV-1 enhancer/promoter plasmid pLTR-CAT
(35) and the polyamide-binding site derivatives which were generated by mu-
tagenesis. These probes were labeled at the 3 end of the top strand at the
HindIII site, which is located at nucleotide position80 within the HIV-1 coding
sequence. Labeling with [-32P]dATP and Klenow DNA polymerase was carried
out as recommended by the supplier (Roche Molecular Biosystems). After di-
gestion with EcoRV (which cleaves at nucleotide position 340 from the tran-
scription start site), the labeled 420-bp fragment was recovered from a nonde-
naturing polyacrylamide gel. Footprinting reaction mixtures contained
approximately 1 ng of the labeled fragment in a 100-l binding reaction mixture
and yielded a DNA concentration of approximately 40 pM in a buffer containing
25 mM Tris-Cl, pH 8.0, 50 mM KCl, 0.1 mM dithiothreitol, 0.5 mM EDTA, 6.25
mM MgCl2, 10% (vol/vol) glycerol, and 0.002% (vol/vol) NP-40. Binding reac-
tion mixtures contained the final concentrations of polyamides indicated in the
figure legends. Where indicated in the figure legends, recombinant human TBP
(Promega) was included at a final concentration of 35 nM and recombinant
TFIIA (a gift from Tae-Kyung Kim and D. Reinberg, University of Medicine and
Dentistry of New Jersey) (37) was included at a final concentration of 216 nM.
These concentrations were determined to be saturating in pilot titration exper-
iments. Incubations were for the times indicated in the figure legends prior to
digestion with 0.025 U of DNase I (Roche) for 30 s at 23°C. DNase I was diluted
into the reaction buffer plus 1 mM CaCl2. Reactions were stopped by the
addition of sodium dodecyl sulfate and EDTA to final concentrations of 0.5%
(wt/vol) and 25 mM, respectively. After extraction with phenol and ethanol
precipitation, the samples were analyzed by electrophoresis on a 6% sequencing
polyacrylamide gel containing 8.3 M urea, 88 mM Tris-borate, pH 8.3, and 2 mM
EDTA. Quantitation of the footprint titrations was by storage phosphorimage
analysis utilizing Kodak storage phosphor screens (SO 230) and a Molecular
Dynamics SF PhosphorImager. The data were analyzed by using the Image-
Quant software from Molecular Dynamics. Volume integration of the target site
was corrected in each lane of the footprint gel by reference to a site in which the
extent of DNase I digestion did not vary across either the TBP or polyamide
titration. Site intensities were calculated after background subtraction, and bind-
ing affinities were determined using a nonlinear least-squares fitting procedure
with KaleidaGraph software (version 3.0.1; Synergy Software). An electro-
phoretic mobility shift assay (EMSA) was used to assess inhibition of TFIID-
TFIIA-DNA interactions. TFIID was purified from HeLa cells using an immu-
noaffinity isolation procedure (11). HeLa cell nuclear extracts were first
fractionated by phosphocellulose chromatography (10), and proteins eluting
between 0.5 and 1.0 M KCl were pooled. TFIID was further immunopurified
using an anti-hTAFII130 monoclonal antibody. Immunoprecipitated material
was washed extensively, and TFIID was specifically eluted from antibody beads
with 2 column volumes of buffer containing an epitope peptide. Binding reaction
mixtures contained 3 ng of the 32P-labeled HIV-1 DNA fragments described
above (yielding a final concentration of 0.6 nM in 20 l) and empirically deter-
mined amounts of TFIID (at a 4 nM final concentration) and recombinant
TFIIA (at a 240 nM final concentration) in a buffer consisting of 10 mM Tris-Cl,
pH 7.9, 10 mM HEPES, pH 7.9, 10% glycerol, 6 mM MgCl2, 50 mM KCl, 100 g
of bovine serum albumin/ml, and 1 mM dithiothreitol. DNA and polyamides
FIG. 1. Polyamide structures and binding sites. (A) Structures for
polyamides ImPy--ImPy--ImPy--ImPy--Dp (1), ImIm--ImIm--
PyPy--PyPy--Dp (2), and ImPy--PyIm-daba-PyIm--ImPy--Dp
(3). Base sequence specificity depends on side-by-side pairing of Py
and Im amino acids in the minor groove of DNA (6). Im-Py targets
G·C base pairs and Py-Im targets C·G base pairs. Py-Py is degenerate
and targets both A·T and T·A base pairs. The -alanine–-alanine pair
also recognizes both A·T and T·A base pairs (42). Black and white
circles, Im and Py rings, respectively; curved line, hairpin junction,
which is formed with -aminobutyric acid or daba; diamonds, -ala-
nine; parenthesis with plus sign, Dp. The positive charge on the daba
turn amino acid (3) is not shown. Me, methyl. (B) DNA sequences of
the HIV-1 promoter constructs (from nucleotide positions 55 to 1,
with respect to the transcription start site at 1), with polyamide
binding sites at various distances upstream (U) or downstream
(D) from the TATA box (boxed). Polyamide-binding models are
shown.
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were preincubated for 15 min at ambient temperature prior to the addition of
TFIIA and TFIID. After a subsequent incubation for 20 min at 30oC, the
reaction mixtures were subjected to electrophoresis on a nondenaturing 6%
polyacrylamide gel containing 44 mM Tris-borate, pH 8.3, 1 mM EDTA, and 5
mM magnesium acetate and measuring 20 cm by 20 cm by 0.75 mm. Gels were
prerun for 45 min and run for 3.5 h, both at 250 V at 4°C, with 44 mM
Tris-borate, pH 8.3–1 mM EDTA–5 mM magnesium acetate as the electro-
phoresis buffer. Gels were dried and subjected to phosphorimage analysis.
Affinity cleavage reactions with polyamide 3-EDTA·Fe(II). Iron-mediated
DNA cleavage under reducing conditions was performed as described previously
(43). Briefly, reactions were performed by first incubating the desired concen-
trations of polyamide 3-EDTA with end-labeled DNA (40 pM final concentra-
tion) for 1 h in buffer consisting of 10 mM Tris-Cl, pH 7.6 and 20 mM NaCl,
followed by addition of freshly prepared ferrous ammonium sulfate
(Fe[NH4]2[SO4]2  6H2O) to a 10 M final concentration. After incubation for
30 min, dithiothreitol was added to a final concentration of 10 mM, and the
cleavage reaction was allowed to proceed for 10 min at ambient temperature.
Reactions were terminated by the addition of EDTA to 25 mM, and the DNA
was precipitated with ethanol and analyzed on a sequencing gel as described
above.
Cell extracts, DNA templates, and in vitro transcription reactions. HeLa
nuclear extract was purchased from Promega. Two microliters of extract and 100
ng of template DNA per 25-l transcription reaction mixture were used as
described previously (30). Runoff RNA transcripts of 500 bases were obtained
with EcoRI-digested plasmid DNA, and transcripts of 200 bases were obtained
with StuI-digested DNA. Plasmid DNA was digested with these enzymes along
with EcoRV, and the promoter-containing DNA fragments were purified from
0.8% agarose gels with the Qiagen QIAquick gel extraction kit. DNA concen-
trations were determined by ethidium staining of an analytical agarose gel by
using known DNA concentrations as standards. Polyamide-DNA complexes
were allowed to form at ambient temperature for 30 min prior to addition of
extracts and other reaction components. After a subsequent incubation at 30°C
for 1 h, transcription reactions were allowed to proceed for 45 min at 30°C.
Reactions were stopped by the addition of an equal volume of a buffer containing
2% sodium dodecyl sulfate and 50 mM EDTA. After extraction with RNAzol
(TelTest), RNA was precipitated with isopropanol and subjected to electro-
phoresis on a 6% polyacrylamide sequencing gel. The dried gels were subjected
to phosphorimage analysis to estimate relative levels of RNA transcripts.
RESULTS
Inhibition of TBP binding with Py-Im polyamides. Previous
studies established that polyamide 1 (ImPy--ImPy--ImPy--
ImPy--Dp [, -alanine; , -aminobutyric acid; Dp, dimeth-
ylaminopropylamide]; Fig. 1A), which binds upstream and
downstream of the HIV-1 TATA element (Fig. 1B, wild type),
inhibits TBP binding to the HIV-1 TATA box (7). Quantitative
DNase I footprint titration experiments showed that poly-
amide 1 binds this sequence with an equilibrium dissociation
constant (Kd) of 0.05 nM (7). Mismatch control polyamide 2
(ImIm--ImIm--PyPy--PyPy--Dp; Fig. 1A), which differs
from polyamide 1 only in the placement of the Py and Im
amino acids, binds this DNA with 100-fold-reduced affinity
relative to polyamide 1. No inhibition of TBP binding was
observed for mismatch polyamide 2 over the polyamide con-
centration ranged tested (7). We wished to examine the effect
of polyamides bound at various distances from the TATA box
on TBP binding. To this end, site-directed mutagenesis was
used to generate binding sites for polyamide 3 (ImPy--PyIm-
daba-PyIm--ImPy--Dp [daba, R-2,4-diaminobutyric acid];
Fig. 1A) at various distances (up to 20 bp) either upstream (U)
or downstream (D) of the HIV-1 TATA box (Fig. 1B). Ac-
cording to the polyamide pairing rules (4), polyamide 3 binds
the DNA sequence 5-WGCWCGW-3 (where W	 A or T) in
either a forward orientation (amino- to carboxy-terminal poly-
amide orientation relative to the 5-to-3 DNA sequence) or
reverse (carboxy- to amino-terminal) orientation (Fig. 1A, bot-
tom). The preference for forward or reverse binding is likely
due to small energetic differences caused by the base compo-
sition of the flanking DNA sequence. The constructs shown in
Fig. 1B are denoted relative to the first T of the TATA box
(1). For example, construct D6 has the first nucleotide of
the polyamide-binding site located at nucleotide position 6
downstream from T1. DNase I footprint titrations revealed
that polyamide 3 binds these constructs with Kds ranging from
2.0 to 6.0 nM (Table 1). Representative examples of these
footprint titrations are shown in Fig. 2A for the U1 and
U10 constructs, and graphical representations of these titra-
tions are shown in Fig. 2B. In addition to the engineered sites
for polyamide 3, each of the constructs contains a match site
for polyamide 3 at nucleotide positions113 to119 from the
transcription start site in the wild-type HIV-1 promoter/en-
hancer sequence (5-AGCTCGA-3; read on the bottom
strand). High-affinity binding to this site is also observed in the
footprinting experiments (Fig. 2A).
To determine the exact location and orientation of the
bound polyamide in the minor groove, site-specific oxidative
cleavage of the DNA with polyamide 3-EDTA·Fe(II) (Fig. 1A)
was employed (43). This DNA cleavage method relies on the
TABLE 1. Polyamide 3 binding affinities and inhibition constants
Construct Site position relativeto T1 Kd (nM)
a TBP inhibition
IC50 (nM)b
Relative
transcriptionc
Transcription inhibition
IC50 (nM)d
U20 26 to 20 NDe 
200f 0.79 50
U15 21 to 15 ND 
200 0.78 75
U10 16 to 10 4.0 
200 0.96 50
U2 8 to 2 4.6 17.5 1.10 25
U1 7 to 1 5.1 12.5 0.38 20
U1 6 to 1 6.0 10.0 0.05 ND
D6 6 to 12 2.7 10.0 0.52 20
D8 8 to 14 4.7 35 0.65 50
D10 10 to 16 2.0 
200 0.41 
200
D15 15 to 21 ND ND 0.97 75
a Determined by quantitative DNase footprinting under equilibrium conditions.
b Polyamide concentration required for half-maximal occupancy of TBP, as determined by DNase footprinting.
c Transcription in the absence of polyamides relative to wild type.
d Polyamide concentration required for 50% inhibition of transcription (see Fig. 7).
e ND, not determined.
f 
200, no inhibition observed up to 200 nM polyamide.
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generation of hydroxyl radicals by iron-mediated Fenton
chemistry under reducing conditions. Since DNA cleavage oc-
curs proximal to the polyamide-EDTA-tethered iron, the lo-
cations of cleavage sites thus determine the position and ori-
entation of the bound polyamide (43). Figure 3A shows the
affinity cleavage patterns with polyamide 3-EDTA · Fe(II) for
each of the DNA constructs where polyamide sites are either
adjacent to or overlap the TATA box. In each instance, the
affinity cleavage pattern demonstrates binding to the engi-
neered sites for polyamide 3 (Fig. 3B) and to the 113-to-
119 match site. Lower levels of DNA cleavage are observed
at mismatch sites (such as at the polyamide 1 match site,
5-AGCTGCA-3, on the downstream side of the TATA box in
U1, U1, and D6). The affinity cleavage results are sum-
marized in Fig. 3B. For some constructs, binding at the engi-
neered sites is predominantly in the forward (N3C) orienta-
tion (U1, U1, and D6). Note that there are two potential
match sites for polyamide 3 in the U1 construct (at nucleo-
tides 10 to 4 on the top strand and at 7 to 1 on the
bottom strand); however, phosphorimage analysis of the affin-
ity cleavage reaction indicates a threefold-greater preference
for the 7-to-1 site than for the 10-to-4 site. Binding in
the reverse (C3N) orientation is observed for the D8 con-
struct, and both orientations are seen with the U10 and
U15 constructs (data not shown). Polyamide orientations in
these constructs can be explained by a preference for the poly-
amide to locate its carboxy-terminal Dp tail adjacent to an
A  T base pair (4). These data confirm the presence of the
polyamide at each of the engineered binding sites in these
constructs.
We next monitored polyamide inhibition of TBP binding to
each of the HIV-1 promoter constructs (Fig. 1B) using DNase
I footprinting. Two examples of these experiments are shown
in Fig. 4. TBP and polyamide 3 yield distinct footprints on
these DNAs (Fig. 4A; compare lanes 3 and 4) such that dis-
placement of TBP by the polyamide can be easily ascertained
(such as for the D6 construct; Fig. 4A). Graphical represen-
tations of the data for each of the constructs are shown in Fig.
5A and B, and 50% inhibitory concentration (IC50) values
obtained from these titrations are given in Table 1. The IC50
values observed for constructs U2, U1, U1, and D6
range from 1.7- to 3.8-fold higher than the Kds for polyamide
3 binding to each of these constructs (Table 1). Polyamide 3 is
an effective inhibitor of TBP binding when the 3 terminus of
its binding site is located either at nucleotide position 1 of
the TATA box (U1) or up to 2 bp upstream (U2); however,
no inhibition is observed when the binding site is 10 bp up-
stream (U10; Fig. 5A). From affinity cleavage experiments
(Fig. 3 and 1B), we conclude that polyamide 3 points in oppo-
site orientations on the U1 and U1 constructs. For U1,
the Dp tail likely extends into the TATA box at T1, while the
charged turn amino acid contacts this base pair on the U1
construct. Since similar IC50 values for TBP inhibition were
obtained with these DNAs (Table 1), this suggests that poly-
amide orientation is not likely to be a critical factor for inhi-
bition of TBP binding, at least on the upstream side of the
TATA box.
Based on the crystal structure of the TBP-DNA complex (24,
25), the full extent of the binding site for TBP is the 8-bp DNA
sequence shown in Fig. 1B. Thus, in constructs D6 and D8,
the polyamide-binding site overlaps the TATA box, and con-
sequently polyamide 3 inhibits TBP binding to these DNAs
(Fig. 5B). Inhibition is observed at lower polyamide concen-
trations with the D6 construct than with the D8 construct.
Polyamide 3 fails to inhibit TBP binding when the polyamide
site is placed as little as 2 bp downstream of the TATA box
(D10). This contrasts with inhibition when the polyamide-
binding site is located 2 bp upstream of the TATA box (U2).
The structural basis for this difference in upstream versus
downstream inhibition profiles is addressed below.
In the situations where polyamide 3 fails to inhibit TBP
binding (U20, U15, U10, D10), DNase footprinting
reveals a triple complex of TBP, polyamide 3, and the DNA.
One such example of polyamide and TBP co-occupancy, for
the D10 construct, is shown in Fig. 4B. In this instance,
FIG. 2. DNase I footprint analysis of polyamide 3 binding.
(A) DNase I footprint of two upstream constructs, U1 (lanes 1 to 10)
and U10 (lanes 11 to 20). Lanes 1 and 11, DNA alone; lanes 2 to 10
and 12 to 20, polyamide 3 at 1, 3, 5, 10, 15, 20, 30, 40, and 50 nM,
respectively. The locations of the polyamide binding sites, TATA box,
transcription start site (denoted 1), and direction of transcription
(arrow) are indicated. The match site at 113 to 119 is also indi-
cated. 32P, end label on the DNA probe. (B) Graphical representation
of polyamide 3 titration plotted as the fraction of DNA bound (nor-
malized to the fraction bound in the absence of polyamide) versus
polyamide concentration.
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protection from DNase I digestion across both the TATA box
and the polyamide binding site is observed (Fig. 4B, lanes 8 to
10); however, close inspection of the TATA box region reveals
a reduced occupancy by TBP in the presence of the polyamide
(compare lane 4 with lanes 8 to 10). For the U10 construct,
in which the polyamide site is farther away from the TATA
box, no decrease in TBP affinity was observed on polyamide
binding (data not shown). We note that there is no correlation
between polyamide binding affinity and the ability of the poly-
amide to inhibit TBP binding (Table 1). Thus, we conclude that
the position of the polyamide-binding site relative to that of
the TATA box and the upstream versus downstream location
determine whether or not the polyamide will be inhibitory to
TBP binding.
We also determined the Kds for polyamide binding in the
presence and absence of TBP to determine whether TBP af-
fected the affinity of the polyamide for its target sequence. We
found that polyamide-binding affinity was unaffected by the
presence of TBP in the reaction mixtures, both for those con-
structs where polyamide 3 inhibited TBP binding and for those
constructs where polyamide 3 and TBP co-occupied the DNA.
An example of such polyamide-binding data is shown in Fig.
5C for the D6 construct. Thus, TBP neither enhances poly-
amide binding nor acts as a competitive inhibitor of the poly-
amide.
Inhibition of the ternary TBP-TFIIA-DNA complex. We next
examined whether polyamide 3 could inhibit formation of the
ternary TBP-TFIIA-DNA complex. General transcription fac-
tor TFIIA has been shown to greatly stabilize the binary TBP-
DNA complex (reviewed in references 33 and 39). Comparison
of the DNase footprints of these binary and ternary complexes
on the HIV-1 promoter clearly supports this view (compare
FIG. 3. Affinity cleavage with polyamide 3-EDTA·Fe(II). (A) Each
of the indicated radiolabeled DNAs (at 40 pM) was incubated with
polyamide at a final concentration of 5 nM (lanes ) or without
polyamide (lanes), and affinity cleavage reactions were performed as
described in Materials and Methods. GA sequencing reactions are
also shown. The location of the TATA box (vertical bar) and nucleo-
tide positions relative to T1 of the TATA box are indicated. Arrow,
location of the transcription start site and direction of transcription; ,
match site at nucleotide positions 113 to 119, relative to the tran-
scription start site, in each of the constructs. (B) DNA sequences of the
HIV-1 promoter constructs (from nucleotide positions 44 to 6,
with respect to the transcription start site). Polyamide-binding sites are
in boldface, and the TATA sequence is boxed. Vertical lines, results
for affinity cleavage with polyamide 3-EDTA·Fe(II), with the height
and width of each line proportional to cleavage intensity at a given site.
FIG. 4. Inhibition of TBP binding to the TATA box by polyamide
3. (A) DNase I footprint of the radiolabeled D6 DNA in the pres-
ence of DNA alone (lane 2); 40 nM polyamide 3 (lane 3); TBP (lane
4); and TBP and polyamide 3 at 3, 5, 10, 15, 20, 30, and 40 nM (lanes
5 to 11, respectively). Lane 1, GA sequencing ladder. (B) Co-occu-
pancy of TBP and polyamide 3. DNase I footprint of D10 in the
presence of DNA alone (lane 2); 40 nM polyamide 3 (lane 3); TBP
(lane 4); and TBP and polyamide 3 at 3, 5, 10, 20, 30, and 40 nM (lanes
5 to 10, respectively). Lane 1, GA sequencing ladder.
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lanes 3 and 4 of Fig. 6A). Far more protection of the DNA
backbone is observed in the presence of TFIIA than with TBP
alone even though a saturating concentration of TBP was used
in these experiments. The crystal structure of the ternary com-
plex shows that TFIIA interacts with the carboxy-terminal re-
gion of TBP, with the backbone of TATA box DNA, and with
the 5 flanking region of the TATA box (12, 38). Since TFIIA
contacts the phosphodiester backbone of DNA upstream of
the TATA box, we next asked whether polyamide 3 could
inhibit formation of the TFIIA-TBP-DNA ternary complex on
U2 DNA (Fig. 6A, lanes 5 to 10). This construct was used
since the polyamide-binding site is coincident with the contacts
made by TFIIA in the ternary complex (12, 38). In this exper-
iment, all reaction components were incubated simultaneously
for 30 min prior to digestion with DNase I. Clearly, the TFIIA-
TBP footprint (lane 4) changes to the polyamide footprint
(lane 11) with increasing concentrations of polyamide 3. Figure
6B shows a graphical representation of the inhibition data for
the binary TBP-DNA complex and for the ternary TBP-
TFIIA-DNA complex. As expected from the relative stabilities
of the binary and ternary complexes, an approximately two-
fold-higher concentration of polyamide 3 is required for inhi-
bition of the ternary TFIIA-TBP-DNA complex than for inhi-
bition of the TBP-DNA complex. Nonetheless, polyamide 3 is
an effective inhibitor of TBP-TFIIA-DNA complex formation.
Polyamide inhibition of transcription. Previous studies have
established that polyamide 1, located adjacent to the TATA
box (Fig. 1B), is an effective inhibitor of basal transcription
from the HIV-1 promoter (7). We wished to know whether
targeting sites distant from the TATA element with poly-
FIG. 5. The effects of distance on inhibition of TBP binding to the
TATA box by polyamide 3. Shown is a graphical representation of
footprint analysis of polyamide inhibition plotted as fraction of DNA
bound (normalized to the fraction of DNA bound in the absence of
polyamide) versus polyamide concentration. (A) Upstream constructs.
(B) Downstream constructs. (C) Polyamide-binding affinity in the pres-
ence and absence of TBP for the D6 construct.
FIG. 6. Inhibition of the ternary TBP-TFIIA-DNA complex by
polyamide 3. (A) DNase I footprint of U2 DNA in the presence of
DNA alone (lane 2); TBP (lane 3); TBP plus TFIIA (lane 4); TBP,
TFIIA, and polyamide 3 at 3, 10, 15, 20, 30, and 50 nM (lanes 5 to 10,
respectively). All reaction components were incubated simultaneously
for 30 min prior to digestion with DNase. Lane 1, GA sequencing
ladder; lane 11, 50 nM polyomide 3, no TBP or TFIIA. The location of
the TATA box and polyamide-binding site are indicated. (B) Graph-
ical representation of inhibition plotted as the fraction of DNA bound
(normalized to the fraction of TBP bound in the absence of polyamide)
versus polyamide concentration.
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amides might also result in inhibition of transcription. To this
end, we monitored the effect of polyamide 3 on basal tran-
scription from each of the promoter constructs shown in Fig.
1B. For these experiments, we used a HeLa nuclear extract as
a source of general transcription factors and RNA polymerase
II for runoff transcription (Fig. 7). Digestion of the wild-type
HIV-1 pLTR-CAT DNA with StuI results in a template that
generates an 200-base RNA transcript, while digestion of the
promoter mutant constructs with EcoRI results in templates
that generate 500-base transcripts (Fig. 7A and B). With the
exception of U1, each of the constructs supports basal HIV-1
transcription with activities ranging from 40 to 110% of that of
the wild-type promoter (Table 1). These observations are in
accord with previous studies with the HIV-1 promoter (20).
The finding that the U1 template failed to support transcrip-
tion could reflect a deleterious effect of altering the DNA
sequence immediately flanking the TATA box on binding one
of the general transcription factors. Thus, this construct was
not included in our polyamide transcription experiments.
Fig. 7B shows an example of a transcription inhibition ex-
periment comparing the wild-type HIV-1 promoter with the
D6 construct. As expected (7), wild-type transcription is in-
hibited by match polyamide 1 (lane 2), while no inhibition is
observed with mismatch polyamide 2 at the same polyamide
concentration (500 nM; lane 3). Also as expected, polyamide 3
inhibits transcription from the D6 template (lanes 5 to 8) and
mismatch polyamide 2 does not (lane 9). The IC50 value ob-
served in this experiment is approximately 20 nM (Fig. 7C;
FIG. 7. Inhibition of basal transcription. (A) Schematic representation of wild-type and mutant construct transcripts. The polyamide binding
sites, TATA box, and approximate transcription start sites are indicated as for Fig. 1. (B) Runoff transcription of wild-type and D6 constructs
monitored with a HeLa nuclear extract (see Materials and Methods). Lanes 1 to 3, wild-type DNA; lanes 4 to 9, D6 DNA. The DNA was
incubated with no polyamide (lane 1); 500 nM polyamide 1 (lane 2); 500 nM mismatch polyamide 2 (lane 3); no polyamide (lane 4); polyamide
3 at 50, 100, 300, and 500 nM (lanes 5 to 8, respectively); and 500 nM mismatch polyamide 2 (lane 9). (C) Graphical representation of inhibition
plotted as percent transcription (normalized to the no-polyamide control reaction) versus polyamide concentration for D6. (D) Relative
transcription signals for each of the indicated DNA constructs (Fig. 1B) are plotted versus polyamide 3 concentration. Transcription levels for each
template were normalized to the level observed in the absence of polyamide.
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Table 1). This concentration corresponds to an equimolar ratio
of polyamide to binding sites in the transcription reaction mix-
ture (24 nM sites). This calculation is based on the amount of
DNA in the reaction mixture (100 ng of an 840-bp DNA
template/25 l reaction mixture) and the presence of three
binding sites for polyamide 3 in the template DNA (two sites
in the HIV-1 promoter and one in the chloramphenicol acetyl-
transferase gene).
Similar experiments were performed for each of the pro-
moter constructs, and a graphical representation of the data is
shown in Fig. 7D. IC50 values obtained from these and other
experiments are listed in Table 1. Inhibition of transcription is
achieved by targeting polyamide 3 to each of the DNA tem-
plates, with the exception of D10. Notably, transcription
from this template is only minimally affected by the polyamide,
even at polyamide concentrations that result in severe inhibi-
tion from each of the other constructs. This result is not due to
a decreased polyamide affinity for this DNA construct (Fig. 4B;
Table 1), and this result has been obtained in four independent
experiments (data not shown). These findings suggest that the
binding of polyamide 3 to the minor groove immediately down-
stream of the TATA element fails to interfere with any re-
quired protein-DNA interaction necessary for basal transcrip-
tion. In contrast, in situations where polyamide 3 either affects
TBP binding (U1, U2, D  6, and D  8) or fails to affect
TBP binding (U10, etc.; Table 1), inhibition of transcription
is observed. These observations suggest that sites of critical
protein-DNA interactions are not simply restricted to the
TATA box but rather lie both upstream and downstream of
this sequence element. These contacts are unlikely to be highly
DNA sequence specific since mutagenesis failed to uncover
any critical sequences outside of the TATA element (Table 1)
(20).
To insure that the results obtained with our series of mutant
promoter constructs would also be true for the wild-type
HIV-1 sequence, a polyamide was designed to bind a site
overlapping the sequence bound by polyamide 3 in the D15
construct. This polyamide, ImImPyPy--PyPyImPy--Dp, binds
the sequence 5-TTGCCT-3, located at nucleotide positions
17 to 22 downstream from T1, and is also a potent in-
hibitor of transcription from the wild-type HIV-1 promoter
(data not shown).
Inhibition of the TFIID-TFIIA-DNA complex. We wished to
know whether the transcription inhibition we observe with
constructs harboring polyamide sites distant from the TATA
box might reflect inhibition of recruitment of one of the basal
transcription factors to the HIV-1 promoter. One such factor is
TFIID, which consists of TBP and TBP-associated factors
(TAFs) (reviewed in references 16, 28, and 33). TFIID binding
to core promoters is greatly stabilized by TFIIA, and such
binding to the HIV-1 promoter has been demonstrated by gel
mobility shift assays (22). DNase I footprinting demonstrates
that TFIID binds over an extended region, generally spanning
nucleotides 40 to 25 relative to the transcription start site
(references 2 and 11 and references therein). For the HIV-1
promoter, DNase I footprinting experiments with HeLa nu-
clear extracts documented protein-DNA contacts over a simi-
lar region (15); however, no direct footprinting experiments on
the HIV-1 promoter with purified TFIID have been presented.
To determine whether the inhibition of transcription ob-
served with constructs containing polyamide binding sites dis-
tant from the TATA box may be due to inhibition of TFIID-
DNA interactions, we used a gel mobility shift assay with the
U15 and D15 constructs and highly purified TFIID and
recombinant TFIIA. Human TFIID was immunopurified using
an anti-hTAFII130 monoclonal antibody, washed extensively
with solutions containing high concentrations of salt, and
eluted from an antibody affinity resin with an epitope peptide
(11). While this preparation of TFIID, in combination with
TFIIA, has been shown to fully saturate a DNA fragment
derived from the adenovirus major-late promoter (11), full
protection of the HIV-1 probe was not observed in similar
footprinting experiments (data not shown). Thus, we used
EMSA to assess polyamide inhibition of TFIID and TFIIA
binding to the HIV-1 promoter. Figure 8A and B demonstrates
that polyamide 3 inhibits formation of this multiprotein com-
plex on both the D15 and U15 DNAs, with IC50s of ap-
proximately 150 and 50 nM, respectively, for these constructs
(Fig. 8C). These IC50 values are similar to the IC50 for inhibi-
tion of transcription on these templates (75 nM; Table 1),
FIG. 8. Polyamide 3 inhibition of the TFIID-TFIIA-DNA complex
analyzed by EMSA. (A) Radiolabeled D15 DNA was incubated with
either no polyamide (lanes ) or with 25, 50, and 200 nM polyamide
3 or 200 nM polyamide 1 for 15 min prior to the addition of TFIID plus
TFIIA, as indicated. After a subsequent 20-min incubation, the sam-
ples were subjected to electrophoresis. Only the region of the gel
containing the TFIID-TFIIA-DNA (DA-DNA) complex is shown.
(B) Radiolabeled U15 DNA was incubated with either no polyamide
or with 50, 100, and 200 nM polyamide 3 or 200 nM polyamide 2 for
15 min prior to the addition of TFIID plus TFIIA, as for panel A.
(C) Phosphorimage quantitation of the extent of DA-DNA complex
formation with increasing concentrations of polyamide 3. Data are
normalized to the phosphorimage units in the DA-DNA complex in
the absence of polyamide.
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suggesting that transcription inhibition is likely due to blocking
TFIID and/or TFIIA access to these templates. As expected,
polyamide 1, with a binding site on the upstream side of the
TATA box in the D15 construct, also inhibits formation of
the TFIID-TFIIA-DNA complex (Fig. 8A). As a control, we
found that mismatch polyamide 2 inhibits formation of the
TFIID-TFIIA-DNA complex on the U15 construct by only
50% at a polyamide concentration where nearly complete
inhibition is observed with match polyamide 3 (200 nM; Fig.
8B). These data suggest that transcription inhibition on the
D15 and U15 constructs may be due to polyamide inter-
ference with recruitment of TFIID.
DISCUSSION
Py-Im polyamides have been used to inhibit the DNA bind-
ing activity of several classes of eukaryotic transcription factors
(reviewed in reference 13). In the present study, we have
shown that polyamides targeted to sequences either immedi-
ately upstream or downstream from the HIV-1 TATA element
effectively inhibit TBP binding. Polyamides are effective inhib-
itors of TBP-DNA interactions when the binding site for the
polyamide is close to or overlaps the TATA box. We suspect
that polyamide inhibition of TBP binding could result from two
possible mechanisms. For those polyamides that bind to sites
overlapping the TATA box (U1, U1, D6, and D8),
inhibition could be due to steric blockage of the minor groove.
In these cases, the polyamide might interfere with insertion of
amino acid side chains of TBP between base pair steps 1 and 2
and 7 and 8 of the 8-bp TATA element (24, 25). For U2,
where the binding site is 2 bp upstream of the TATA element,
polyamide 3 binding might lock the DNA into a B-type struc-
ture that is incompatible with TBP binding. Cocrystal struc-
tures have shown that the Py-Im polyamides bind to undis-
torted B-type DNA (23) whereas TBP binding results in a large
distortion of the double helix (24, 25). Thus, at saturating
concentrations of polyamide, it is reasonable to suspect that
the B-type polyamide-DNA complex predominates over the
distorted TBP-DNA structure.
Surprisingly, a polyamide bound 2 bp downstream from the
TATA element can co-occupy the DNA along with TBP
(D10; Fig. 4B), whereas a polyamide bound 2 bp upstream
from the TATA box is inhibitory to TBP binding (Fig. 5A).
This difference between upstream and downstream inhibition
may be related to the fact that the majority of the binding
energy for the TBP-DNA interaction comes from the interac-
tion of the carboxy-terminal repeat region of TBP with the 5
half of the TATA box (21). However, this interpretation as-
sumes that the orientation of TBP in solution on the HIV-1
promoter is that found in the crystal structures (24, 25). Since
affinity cleavage experiments suggest only a modest polarity for
Saccharomyces cerevisiae TBP binding to the TATA element in
solution (5), it may be that the HIV-1 TATA box DNA se-
quence itself imparts polarity to TBP binding. The adenovirus
major-late promoter and cyc1 TATA box sequences used in
the affinity cleavage experiments (5-TATAAAAG-3 and 5-
TATATAAA-3, respectively) clearly differ from that of the
HIV-1 TATA box (Fig. 1B). Additional biochemical data from
DNA cleavage with the drug pluramycin (36) and transcription
experiments (14) demonstrate that TBP can adopt an asym-
metric orientation on some TATA sequences. One alternative
explanation for upstream versus downstream inhibition is that
the polyamide itself can orient TBP on the U10 construct
allowing co-occupancy; indeed, polyamide binding weakens
the affinity of TBP somewhat on this construct (Fig. 4B). Ad-
ditional experiments will be needed to resolve this issue.
We monitored the effect of polyamide 3 on basal transcrip-
tion by RNA polymerase II from our series of DNA constructs
in which the polyamide-binding site was located at various
distances from the TATA box. Fifty percent inhibition of tran-
scription was observed at an approximately equimolar ratio of
polyamide to binding sites for those constructs that contained
polyamide sites either adjacent to or overlapping the TATA
element (Fig. 7D; Table 1). Inhibition of transcription from
constructs such as U2, U1, D6, and D8 could simply be
due to inhibition of the binding of the TBP subunit of TFIID
(Fig. 6A and B). Additionally, it is well established that general
transcription factors (GTFs) TFIIA and TFIIB contact pro-
moter DNA both upstream and downstream of the TATA box
(12, 26, 27, 38, 41), and transcription inhibition with some of
our constructs could be due to steric clashes by the polyamide
with these factors. Crystal structures of the core TFIIA-TBP-
DNA complex reveal protein-DNA phosphate contacts both
within and upstream of the TATA box (12, 38). The poly-
amide-binding site in the U2 construct is coincident with
upstream contacts made by TFIIA in the ternary complex.
Although these contacts are located across the major groove,
polyamide 3 might able to block TFIIA-DNA contacts by sub-
tle changes in groove geometry (23). Indeed, we have shown
that polyamide 3 can block the assembly of the TFIIA-TBP-
DNA complex (Fig. 6).
For TFIIB, biochemical studies have identified a 7-bp TFIIB
recognition element immediately upstream of the TATA box
(26), and a cocrystal structure of the ternary TFIIB-TBP-DNA
complex reveals that TFIIB contacts the major groove of DNA
at this upstream site but also contacts both major and minor
grooves downstream of the TATA box, extending to position
16 from T1 (41). Interestingly, little or no transcription
inhibition is observed with the D10 construct although the
minor-groove contacts made by TFIIB are well within the
binding site for this polyamide. Additionally, photo-cross-link-
ing experiments have identified TFIIA and TFIIB contacts
within this region (27). We suggest that these downstream
TFIIA- and TFIIB-DNA contacts are either not essential or at
least not rate limiting for assembly of the transcription com-
plex and basal transcription.
We also find transcription inhibition with constructs that
harbor polyamide-binding sites further upstream and down-
stream from the TATA element (U20, U15, and D15;
Fig. 7D). Footprinting studies with HeLa nuclear extracts doc-
umented cellular protein-DNA interactions at these sites on
the HIV-1 promoter (15, 19, 20). Candidate proteins for these
interactions are the TAFs of TFIID for both the upstream and
downstream contacts, TFIIA for upstream contacts, and
TFIIB for downstream contacts. Photo-cross-linking experi-
ments demonstrate TFIIA-DNA contacts upstream of the
TATA box extending to 19 from T1 of the TATA element
and TFIIB contacts downstream to 18 (27). We find that
polyamide 3 is a potent inhibitor of TFIID-TFIIA-DNA con-
tacts on both the U15 and D15 constructs, with IC50 values
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for inhibition of these protein-DNA interactions similar to
those for inhibition of transcription (Fig. 8C and Table 1).
Thus, inhibition of transcription with U15 could be due to
interference with either TAF- or TFIIA-DNA contacts and
inhibition with D15 may be due to interference with TAF-
DNA contacts.
It is certainly possible that polyamides inhibit transcription
by blocking the interaction of one of the other GTFs (TFIIE,
-F, or -H) or RNA polymerase II with promoter DNA. Indeed,
photo-cross-linking studies mapped the interactions of TFIIE,
TFIIF, and RNA polymerase II with promoter DNA upstream
from the transcription start site (3, 4, 34). Additionally, poly-
amides might prevent the bending and wrapping of the DNA
around the GTFs or RNA polymerase, as proposed in a model
for transcriptional regulation by Coulombe and Burton (3). In
the present study, however, we considered TBP, TFIID, and
TFIIA as potential candidates for interference by polyamides
since these factors are among the first of the GTFs to bind the
core promoter and since an inhibitor that blocks these inter-
actions with DNA is expected to inhibit transcription from the
targeted promoter. Thus, future studies will be needed to as-
sess which of the GTFs or polymerase is the actual target for
polyamide inhibition with each of the HIV-1 promoter con-
structs.
Our approach, of targeting DNA sequences within core
promoters, might prove effective for inhibition of basal tran-
scription from various mRNA-coding genes. The potential
therapeutic applications of polyamide inhibition of gene tran-
scription have been discussed previously (7). Previous mu-
tagenesis studies of the HIV-1 promoter identified only the
TATA box and sequences flanking the initiation site (6 to
30) as important sequences for basal promoter activity (ref-
erences 20 and 45 and references therein). However, the Py-Im
polyamides clearly identify sites of important protein-DNA
interactions that do not involve sequence-specific DNA inter-
actions. Thus, our present results and our previous study with
a tRNA gene (32) demonstrate that the Py-Im polyamides
provide simple and convenient chemical probes for discovery
of important protein-DNA contacts within a gene promoter.
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